Dilip Shanghvi, chairman and founder of Sun Pharmaceutical Industries Ltd., poses for a photograph in Mumbai. (Photographer: Kanishka Sonthalia/Bloomberg)
(Bloomberg Businessweek) -- You’d be hard-pressed to find someone who’s lost more during the recent upheaval in the generic drug business than Dilip Shanghvi: He forfeited $17 billion to be precise, plus the title of India’s richest man.